Overview
EWTX market data
Price History
EWTX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.63 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.35 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $12.30 – $48.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $4.8B · P/B 5.03.
Company News
Goldman Sachs Maintains Neutral on Edgewise Therapeutics, Raises Price Target to $36Benzinga · Aug 11, 2026, 5:52 PM
Edgewise Therapeutics Q2 EPS $(0.53) Misses $(0.47) EstimateBenzinga · Aug 6, 2026, 12:45 PM
8-K filing — Edgewise Therapeutics, Inc. (EWTX)SEC EDGAR · Aug 6, 2026, 12:05 PM
Evercore ISI Group Maintains Outperform on Edgewise Therapeutics, Raises Price Target to $55Benzinga · Jul 20, 2026, 12:57 PM
Oppenheimer Initiates Coverage On Edgewise Therapeutics with Outperform Rating, Announces Price Target of $51Benzinga · Jul 9, 2026, 1:40 PM
Guggenheim Maintains Buy on Edgewise Therapeutics, Raises Price Target to $51Benzinga · Jul 6, 2026, 2:10 PM
Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For ThursdayBenzinga · Jun 18, 2026, 2:35 PM
RBC Capital Maintains Outperform on Edgewise Therapeutics, Raises Price Target to $59Benzinga · Jun 17, 2026, 3:05 PM
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For WednesdayBenzinga · Jun 17, 2026, 1:10 PM
Goldman Sachs Maintains Neutral on Edgewise Therapeutics, Raises Price Target to $32Benzinga · Jun 17, 2026, 12:25 PM